Clinical Report: CD4+ T Cell Profile in Long COVID: Findings from an Unvaccinated Patient Group
Overview
This study investigates the immune responses in Long COVID patients, focusing on CD4+ T cell profiles in an unvaccinated cohort. Findings reveal distinct immune signatures in Long COVID patients compared to recovered controls.
Background
Long COVID is a complex condition affecting millions, characterized by persistent symptoms following acute SARS-CoV-2 infection. Understanding the immunological mechanisms underlying Long COVID is important. This study aims to elucidate the immune profiles of unvaccinated individuals to minimize confounding factors such as vaccination and reinfection.
Data Highlights
No numerical data or trial data provided in the source material.
Key Findings
Systemic humoral responses to SARS-CoV-2 were similar between Long COVID and recovered control groups.
Distinct immune signatures were identified in CD4+ T cells of Long COVID patients, indicating acute activation.
Increased expression of interferon-alpha/gamma signatures was observed in Long COVID patients compared to recovered controls.
No evidence of clonal expansion in the T cell receptor repertoire was found in Long COVID patients.
CD4+ T cell dysfunction in Long COVID is characterized by non-proliferative activation more than one month after symptom onset.
Clinical Implications
Understanding these immune profiles could inform management of Long COVID.
Conclusion
This study provides insights into the immunological alterations in Long COVID.
by Thiago Cerqueira-Silva, Benjamin Goodwin, Cíntia Araújo, Jessica J. Silva, Blenda de J. Pereira, Ícaro Bonyek Santos da Silva, Sara Nunes, Ananda Marinho, Ana Paula Barreto, Marcio Barreto, Marcelo Chalhoub, Juliana Ribeiro Caldas, Vishal Rao, Camila Coelho, Adolfo Rojas-Hidalgo, Vinicius Maracaja-Coutinho, Ricardo Khouri, Cristina R. Cardoso, Aldina Barral, Manoel Barral-Netto, Natalia Machado Tavares, Jennifer Dan, Viviane S. Boaventura
